Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
6(32%)
Results Posted
30%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
3
16%
Ph phase_1
6
32%
Ph phase_3
3
16%
Ph phase_2
2
11%
Ph early_phase_1
3
16%
Ph phase_4
2
11%

Phase Distribution

9

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution19 total trials
Early Phase 1First-in-human
3(15.8%)
Phase 1Safety & dosage
6(31.6%)
Phase 2Efficacy & side effects
2(10.5%)
Phase 3Large-scale testing
3(15.8%)
Phase 4Post-market surveillance
2(10.5%)
N/ANon-phased studies
3(15.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

6

trials recruiting

Total Trials

19

all time

Status Distribution
Active(6)
Completed(10)
Terminated(1)
Other(2)

Detailed Status

Completed10
Recruiting4
Active, not recruiting2
Suspended1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
6
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (15.8%)
Phase 16 (31.6%)
Phase 22 (10.5%)
Phase 33 (15.8%)
Phase 42 (10.5%)
N/A3 (15.8%)

Trials by Status

completed1053%
active_not_recruiting211%
suspended15%
recruiting421%
terminated15%
unknown15%

Recent Activity

6 active trials
Showing 5 of 19
recruitingnot_applicable

The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder

NCT07324057
terminatednot_applicable

Platelet Lysate vs Saline for Lumbosacral Radiculopathy

NCT06924853
suspendedphase_1

In-office Repair of Chronic Tympanic Membrane Perforations

NCT06448039
recruitingphase_3

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

NCT07207369
recruitingearly_phase_1

Autonomic Control of the Circulation and VDR

NCT03513770
View all 19 trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT07324057Not Applicable

The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder

Recruiting
NCT06924853Not Applicable

Platelet Lysate vs Saline for Lumbosacral Radiculopathy

Terminated
NCT06448039Phase 1

In-office Repair of Chronic Tympanic Membrane Perforations

Suspended
NCT07207369Phase 3

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Recruiting
NCT03513770Early Phase 1

Autonomic Control of the Circulation and VDR

Recruiting
NCT06778811Phase 4

Clinical Study of Perioperative Sleep Disorders in Cardiac Surgery

Recruiting
NCT03953196Early Phase 1

A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants

Completed
NCT02216838Phase 4

Treatment of Facial Flushing With Botulinum Toxin A Injections

Active Not Recruiting
NCT05011357Early Phase 1

Phenylephrine and Pulse Pressure Variability

Completed
NCT04848272Phase 1

Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury

Active Not Recruiting
NCT04392778Phase 1

Clinical Use of Stem Cells for the Treatment of Covid-19

Completed
NCT04883996Phase 1

A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia

Unknown
NCT03229759Phase 2

Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Completed
NCT01531699Phase 3

Antimicrobial Efficacy of ALT005 Ophthalmic Prep Solution in Healthy Volunteers

Completed
NCT02086500Phase 3

Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)

Completed
NCT02146781Phase 1

A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device

Completed
NCT02185729Phase 2

Comparing Soybean Oil-Based (Intralipid) With an Olive Oil-Based (ClinOleic) Lipid Emulsion on Healthy Volunteers

Completed
NCT00803348Not Applicable

Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty

Completed
NCT00393445Phase 1

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19